Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537 infants (enrolled at 6–12 weeks) were 1:1:1-randomi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Guerra Mendoza, Yolanda, Garric, Elodie, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Pirçon, Jean-Yves, Stegmann, Jens-Ulrich, Vandoolaeghe, Pascale, Otieno, Lucas, Otieno, Walter, Owusu-Agyei, Seth, Sacarlal, Jahit, Masoud, Nahya Salim, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Mtoro, Ali Takadir, Njuguna, Patricia, Oneko, Martina, Otieno, Godfrey Allan, Otieno, Kephas, Gesase, Samwel, Hamel, Mary J, Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lusingu, John, Malabeja, Anangisye, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Schuerman, Lode
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816384/
https://ncbi.nlm.nih.gov/pubmed/31012786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1586040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars